- ¥7bn
- ¥5bn
- ¥10bn
- 58
- 70
- 61
- 72
Annual balance sheet for Cosmo Bio Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,259 | 3,555 | 3,036 | 3,025 | 2,693 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,779 | 2,710 | 2,798 | 2,851 | 3,002 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 6,756 | 7,310 | 7,136 | 7,102 | 7,229 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 636 | 599 | 577 | 572 | 701 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 9,640 | 10,072 | 10,313 | 10,872 | 11,723 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,226 | 1,093 | 1,038 | 1,123 | 1,166 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,282 | 2,285 | 2,261 | 2,427 | 2,755 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 7,358 | 7,787 | 8,052 | 8,445 | 8,968 |
Total Liabilities & Shareholders' Equity | 9,640 | 10,072 | 10,313 | 10,872 | 11,723 |
Total Common Shares Outstanding |